Actively Recruiting
Open-Source Artificial Pancreas System Use Among People With Type 1 Diabetes Mellitus in China
Led by Third Affiliated Hospital, Sun Yat-Sen University · Updated on 2024-06-24
500
Participants Needed
1
Research Sites
386 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This real-world observational study aims to reveal the current status of the open-source artificial pancreas system (APS) use among people with T1DM in China and assess the glycemic efficacy and potential related factors of the open-source APS.
CONDITIONS
Official Title
Open-Source Artificial Pancreas System Use Among People With Type 1 Diabetes Mellitus in China
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with Type 1 Diabetes Mellitus
- Currently using an open-source artificial pancreas system for at least 3 months
- Willing and able to provide informed consent or have a legal representative who can
- Reside in China
You will not qualify if you...
null
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Jinhua Yan
Guangzhou, Guangdong, China, 510630
Actively Recruiting
Research Team
J
Jinhua Yan, PHD,MD
CONTACT
W
Wen Xu, PHD,MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here